Ross, D.

disease study worker symptom peak flow measurements subject patient asthma pramipexole heart result probability health heart failure sensitivity laboratory workers specificity laboratory failure testing database l-dopa acid anhydride workers analysis flour workers irritability questionnaire flour measurement ergot exposure surveillance 1/fvc parkinson control agonist health surveillance fev 1/fvc diagnosis history non-ergot nsbhr dopamine effect anhydride group spirometry ratio function peak flow variability research edema health care outcome test outcome non-ergot das screening instruments dopamine agonists cabergoline index date da use cohort screening valve fi brosis identi fied pergolide p fizer bronchitis irritability syndrome criteria pramipexole use framingham criteria acid anhydrides 12 december 2006 dopamine agonist use heart disease treatment number histamine percentile